This is the story of Dave, who, along with his wife Dawn, shared his journey with acute myeloid leukemia (AML) – from diagnosis and clinical trial experience to remission. Since being interviewed, Dave passed away. To continue Dave’s legacy, Dawn keeps sharing his journey with AML as an inspiration to people with cancer, their caregivers and the scientific community. AML is the most common type of aggressive leukemia in adults and has the lowest survival rate of all types of leukemia.¹ AML is a cancer that starts in the bone marrow but can spread quickly to the blood and other parts of the body.² About 20,000 people are estimated to receive an AML diagnosis in the United States in 2023.³

For those living with a rare disease, it can be difficult to talk openly about their journey, even when it comes to crucial conversations surrounding symptoms, and how they are feeling.